Concord Drugs Key Metrics

BSE: 538965 | NSE: - | ISIN: INE858L01010 | Sector: Biotechnology & Drugs

34.75 -1.25 (-3.47%)Updated : 26 Nov 2024

Ratios

Return on average equity - 5 year average	4.80
Net Income/employee - trailing 12 month	-
Revenue/employee - most recent fiscal year	-
Return on investment - most recent fiscal year	1.28
Return on average assets - most recent fiscal year	0.81
Receivables turnover - most recent fiscal year	2.52
Return on investment - trailing 12 month	-1.30
Return on average assets - trailing 12 month	-0.77
Inventory turnover - most recent fiscal year	1.55
Inventory turnover - trailing 12 month	1.84
Revenue/employee - trailing 12 month	-
Return on average assets - 5 year average	2.27
Net Income/employee - most recent fiscal year	-
Return on average equity - trailing 12 month	-1.52
Receivables turnover - trailing 12 month	1.95
Asset turnover - most recent fiscal year	0.77
Asset turnover - trailing 12 month	0.79
Return on average equity - most recent fiscal year	1.44
Return on investment - 5 year average	4.09